Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Septum | 1 | 2016 | 303 | 0.480 |
Why?
|
| Atrial Appendage | 1 | 2016 | 284 | 0.400 |
Why?
|
| Cardiac Resynchronization Therapy | 6 | 2014 | 562 | 0.380 |
Why?
|
| Natriuretic Peptide, Brain | 8 | 2012 | 1736 | 0.380 |
Why?
|
| Sarcoidosis | 1 | 2016 | 532 | 0.350 |
Why?
|
| Heart Failure | 19 | 2020 | 11840 | 0.330 |
Why?
|
| Peptide Fragments | 8 | 2012 | 5125 | 0.290 |
Why?
|
| Receptors, Cell Surface | 3 | 2013 | 2817 | 0.280 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2016 | 1339 | 0.270 |
Why?
|
| Heart-Assist Devices | 7 | 2015 | 1296 | 0.230 |
Why?
|
| Ventricular Remodeling | 2 | 2012 | 1272 | 0.210 |
Why?
|
| Heart Transplantation | 7 | 2015 | 3310 | 0.200 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2015 | 122 | 0.190 |
Why?
|
| Cardiovascular Agents | 3 | 2012 | 851 | 0.180 |
Why?
|
| Dyspnea | 2 | 2020 | 1352 | 0.170 |
Why?
|
| Heart Failure, Systolic | 2 | 2012 | 135 | 0.170 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 3928 | 0.150 |
Why?
|
| Pulmonary Ventilation | 1 | 2020 | 377 | 0.150 |
Why?
|
| Stroke Volume | 2 | 2010 | 5596 | 0.130 |
Why?
|
| Amyloidosis | 2 | 2016 | 885 | 0.130 |
Why?
|
| Outpatients | 3 | 2012 | 1595 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 317 | 0.120 |
Why?
|
| Syncope | 1 | 2016 | 429 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 1005 | 0.110 |
Why?
|
| Remote Consultation | 1 | 2015 | 240 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2012 | 2136 | 0.100 |
Why?
|
| Edema | 1 | 2016 | 760 | 0.100 |
Why?
|
| Amyloidosis, Familial | 1 | 2012 | 15 | 0.100 |
Why?
|
| Echocardiography | 5 | 2016 | 5045 | 0.100 |
Why?
|
| Monitoring, Ambulatory | 1 | 2015 | 357 | 0.100 |
Why?
|
| Ventricular Fibrillation | 1 | 2014 | 533 | 0.090 |
Why?
|
| Leg | 1 | 2016 | 1080 | 0.090 |
Why?
|
| Metabolomics | 1 | 2020 | 1668 | 0.090 |
Why?
|
| Hospitalists | 1 | 2014 | 297 | 0.090 |
Why?
|
| Hypothyroidism | 1 | 2015 | 667 | 0.080 |
Why?
|
| Lung | 2 | 2020 | 10033 | 0.080 |
Why?
|
| Prealbumin | 1 | 2012 | 266 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2020 | 4184 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 2012 | 2067 | 0.080 |
Why?
|
| Graft Rejection | 2 | 2013 | 4499 | 0.080 |
Why?
|
| Aged | 26 | 2020 | 171117 | 0.080 |
Why?
|
| Melphalan | 1 | 2010 | 425 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11499 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1006 | 0.070 |
Why?
|
| Heart Ventricles | 3 | 2011 | 3832 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2010 | 675 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 2476 | 0.070 |
Why?
|
| Hyponatremia | 1 | 2010 | 276 | 0.070 |
Why?
|
| Amyloid | 1 | 2012 | 853 | 0.070 |
Why?
|
| Radiography | 1 | 2016 | 6919 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1363 | 0.060 |
Why?
|
| Treatment Outcome | 16 | 2015 | 65188 | 0.060 |
Why?
|
| Interleukins | 1 | 2010 | 791 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3454 | 0.060 |
Why?
|
| HLA Antigens | 2 | 2007 | 1339 | 0.060 |
Why?
|
| Male | 28 | 2020 | 363698 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 15398 | 0.060 |
Why?
|
| Disease Management | 1 | 2014 | 2535 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2013 | 1799 | 0.060 |
Why?
|
| Prognosis | 9 | 2020 | 29922 | 0.050 |
Why?
|
| Exercise | 1 | 2020 | 5937 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 1315 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4108 | 0.050 |
Why?
|
| Isoantibodies | 1 | 2007 | 681 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 13039 | 0.050 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 39193 | 0.050 |
Why?
|
| Middle Aged | 22 | 2020 | 223009 | 0.050 |
Why?
|
| Female | 30 | 2020 | 396112 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1602 | 0.050 |
Why?
|
| Myocardium | 2 | 2012 | 4760 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2012 | 2966 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12976 | 0.050 |
Why?
|
| Survival Rate | 5 | 2013 | 12795 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2495 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2012 | 2517 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2010 | 4493 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2007 | 1297 | 0.040 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2004 | 363 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2011 | 2643 | 0.040 |
Why?
|
| Humans | 32 | 2020 | 765968 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2012 | 6499 | 0.040 |
Why?
|
| Inpatients | 1 | 2010 | 2564 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2012 | 3286 | 0.040 |
Why?
|
| Systole | 1 | 2020 | 935 | 0.040 |
Why?
|
| Cause of Death | 1 | 2008 | 3708 | 0.040 |
Why?
|
| Retrospective Studies | 11 | 2015 | 81514 | 0.040 |
Why?
|
| Transplantation, Homologous | 3 | 2013 | 4860 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4588 | 0.030 |
Why?
|
| Quality of Life | 3 | 2012 | 13462 | 0.030 |
Why?
|
| Acute Disease | 3 | 2014 | 7232 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2004 | 1476 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 59489 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 841 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15652 | 0.030 |
Why?
|
| Massachusetts | 2 | 2020 | 8875 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2015 | 209 | 0.030 |
Why?
|
| Adult | 12 | 2020 | 223044 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2015 | 219 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2020 | 54802 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 3432 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2012 | 15880 | 0.020 |
Why?
|
| Statistics as Topic | 2 | 2012 | 2352 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5753 | 0.020 |
Why?
|
| Exercise Test | 1 | 2020 | 2180 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 20124 | 0.020 |
Why?
|
| Digoxin | 1 | 2012 | 246 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2014 | 591 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5189 | 0.020 |
Why?
|
| Disease Progression | 3 | 2014 | 13632 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2012 | 9347 | 0.020 |
Why?
|
| Biopsy | 2 | 2012 | 6763 | 0.020 |
Why?
|
| Myocardial Ischemia | 2 | 2014 | 2128 | 0.020 |
Why?
|
| Diuretics | 1 | 2012 | 613 | 0.020 |
Why?
|
| Hospitalization | 3 | 2015 | 10808 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2011 | 460 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 415 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2012 | 5993 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2012 | 1134 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2004 | 845 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10070 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2652 | 0.020 |
Why?
|
| Sex Factors | 2 | 2015 | 10603 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 612 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 538 | 0.020 |
Why?
|
| Standard of Care | 1 | 2011 | 567 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 30198 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2008 | 508 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 1237 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2011 | 966 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 1600 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1514 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2010 | 830 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 2120 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 804 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 827 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 12509 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3620 | 0.010 |
Why?
|
| Time Factors | 2 | 2020 | 40065 | 0.010 |
Why?
|
| Age Factors | 2 | 2012 | 18380 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2010 | 41649 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2004 | 276 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6203 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2475 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2033 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6832 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2004 | 578 | 0.010 |
Why?
|
| Benchmarking | 1 | 2008 | 1052 | 0.010 |
Why?
|
| Cardiac Output | 1 | 2004 | 840 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2844 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12056 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2778 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 2004 | 589 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 899 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 575 | 0.010 |
Why?
|
| Health Status | 1 | 2012 | 4080 | 0.010 |
Why?
|
| Risk Factors | 3 | 2014 | 74840 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2004 | 1602 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2010 | 24282 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2004 | 1003 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14652 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 2004 | 1466 | 0.010 |
Why?
|
| Equipment Design | 1 | 2004 | 3481 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10563 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2004 | 1414 | 0.010 |
Why?
|
| United States | 2 | 2012 | 72903 | 0.010 |
Why?
|
| Aging | 1 | 2012 | 8731 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21480 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8501 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5891 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2004 | 15747 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 2023 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10383 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2004 | 6404 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 26318 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 15842 | 0.010 |
Why?
|
| Stroke | 1 | 2011 | 9747 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2005 | 22223 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 59889 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 36532 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 88835 | 0.000 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_